health pharma news today obesity drugs glp-1 A new oral option is now part of medicine. FDA approved Foundayo (orforglipron), a once-daily oral GLP-1 receptor agonist, for adults with obesity or overweight with at least one weight-related The GLP-1 Revolution: How Next-Generation

Recently, extensive research has revealed foodborne compounds as ferroptosis inducers and their relevant mechanisms in cancer therapy (73)

[13] [14] on the in vitro as well as in vivo effect of L-carnitine tartrate on hair growth

In gilts supplemented with dietary inorganic selenium, Se-GSH-Px increased rapidly and was insensitive to oxidative pressure brought by the peri-estral period, which is in agreement with the situation described in Figure 5

Fahima Azizi Dr

Both types of melanin showed activity against the DPPH and ABTS radicals, but the level of this protection was much lower than in the case of vitamin C

Clin Exp Pharmacol Physiol 2000